SG Americas Securities’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
Other funds holding CLOV
VCM
VPM
SG Americas Securities's CLOV Position: Q1 2026 in Review
SG Americas Securities increased its Clover Health Investments (CLOV) stake by 143% in Q1 2026, buying an estimated $184K and bringing the position to 143,759 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #2536.
SG Americas Securities first reported a position in CLOV in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.75M in Q2 2021. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.
- SG Americas Securities held 143,759 shares of Clover Health Investments worth $253K as of Q1 2026.
- SG Americas Securities bought 84,713 Clover Health Investments shares in Q1 2026, an estimated $184K.
- Clover Health Investments made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2536 holding.
- SG Americas Securities first reported a position in Clover Health Investments in Q1 2021 and has held it in 12 quarters since.
- SG Americas Securities's Clover Health Investments position peaked at $2.75M in Q2 2021.
- 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.